<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body> final stages spliceosome maturation require <br /> Spp2p interact DEAH box protein <br /> Prp2p promote step 1 splicing <br />  <br />  <br /> ABSTRACT <br /> Pre-mRNA processing occurs assembly splicing factors substrate form spliceosome followed consecutive RNA cleavage-ligation reactions. Prp2 protein hydrolyzes <span id='am-52' about='obo:IMR_0001351' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-53' property="oboInOwl:id" content="IMR:0001351" datatype="xsd:string"></span><span id='am-54' property="oboInOwl:hasExactSynonym" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-55' property="oboInOwl:hasDbXref" content="KEGG:C00002" datatype="xsd:string"></span><span id='am-56' property="oboInOwl:hasAlternativeId" content="IMR:0200394" datatype="xsd:string"></span><span id='am-57' property="rdfs:label" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-58' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-59' property="rdfs:label" content="ATP" datatype="xsd:string"></span><span id='am-60' property="oboInOwl:hasAlternativeId" content="IMR:0100127" datatype="xsd:string"></span><span id='am-61' property="oboInOwl:hasExactSynonym" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-62' property="rdfs:label" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span>ATP</span> required reaction (Yean SL, Lin RJ, 1991, Mol Cell Biol 11:5571-5577; Kim SH, Smith J, Claude  Lin RJ, 1992, EMBO <br /> J 11:2319-2326). Saccharomyces cerevisiae SPP2 gene previously identified high-copy suppres- <br /> sor temperature-sensitive prp2 mutants  RL, Maddock JR, Woolford JL Jr, 1987, Genetics 117:619-631). characterized function Spp2p vivo vitro. Spp2p essential protein required RNA cleavage reaction vivo. Depletion Spp2p yeast cells results accumulation unspliced <br /> pre-mRNAs. temperature-sensitive spp2-1 mutant accumulates pre-mRNAs vivo unable undergo splicing reaction vitro.  spliceosomal complexes assembled extracts prepared mutant. Spp2p function required spliceosome assembly prior reac- <br /> tion. Spp2p associates spliceosome RNA cleavage reaction likely released spliceosome following ATP hydrolysis Prp2p. Prp2 Spp2 proteins capable physi- <br /> cally interacting  results suggest Spp2p interacts Prp2p spliceosome <br /> prior cleavage-ligation reaction. Spp2p protein interact DEAD/H box splicing factor. <br /> Keywords: physical interaction; pre-mRNA processing; Saccharomyces cerevisiae <br />  <br />  <br /> INTRODUCTION                                                                  required proper assembly function removal introns nuclear messenger RNA                             spliceosome. <br /> precursors (splicing) takes place trans-esteri-                           widely believed  group group <br /> fication reactions, involving cleavage ligation,                          II introns, pre-mRNA splicing catalyzed RNA. complex ribonucleoprotein particle called                        Spliceosome assembly relies heavily dynamic RNA- <br /> spliceosome  recent reviews, Rymond <span id='am-12' about='obo:IMR_0200083' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-13' property="oboInOwl:hasExactSynonym" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-14' property="rdfs:label" content="AMP" datatype="xsd:string"></span><span id='am-15' property="oboInOwl:hasDbXref" content="KEGG:C00020" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:id" content="IMR:0200083" datatype="xsd:string"></span><span id='am-17' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-18' property="rdfs:label" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span>amp</span>; Ros-                            RNA RNA-protein interactions occur bash, 1992; Moore et al., 1993; Legrain &amp; Chanfreau,                          temporal fashion result productive splicing  <br /> 1994). spliceosome comprised mainly Ul,                         action (reviewed Guthrie, 1991; Madhani &amp; Guthrie, <br /> U2, U4/U6, U5 small nuclear ribonucleoprotein                             1994; Nilsen, 1994). interactions occur <br /> particles (snRNPs) assemble ordered fashion                        different snRNAs. involve pre-mRNA substrate. Additional proteins                            snRNA-pre-mRNA interactions. interactions                                                                               presumed ultimately result formation                                                                               &quot;catalytically active&quot; core initiates trans-ester- <br />     Reprint requests  John L. Woolford, Jr., Department Biolog-         ification reactions. <br /> ical Sciences, Carnegie-Mellon University, Pittsburgh, Pennsylvania <br /> 15213, USA; e-mail: jwl7@andrew.cmu.edu.                                         RNA cleavage-ligation reactions     &apos;Present address: Department Biology, College Natural Sci-          theory require energy, steps ences, Kangwon National University, Kangwon  South Korea.                  assembly function spliceosome ATP- <br />     2 Present address: Department Biology, University Michi- <br /> gan, Ann Arbor, Michigan 48109, USA.                                          dependent. possibility energy used     3 Present address: Igen Corp., Rockville, Maryland 20852, USA.            changes inter- intra-molecular RNA base pair- <br />                                                                         375 <br />  376                                                                                                       J. Roy et al. <br /> ing conformational changes proteins           Linder, 1992; Fuller-Pace, 1994). fact, RNA heli- critical proper splicing. Energy       case  activity eIF4A greatly stimulated quired binding snRNPs proteins          factor, eIF4B (Grifo et al., 1984; Rozen et al., 1990). <br /> assembling spliceosome release            previously reported isolation gene <br /> spliceosome.                                                 SPP2, extra copies suppress temperature- <br />    hard imagine role RNA helicases     sensitive prp2 mutant strains  et al., 1987). process involves extensive changes RNA         Spp2p required pre-mRNA splic- <br /> formations. yeast Saccharomyces cerevisiae,      ing vivo vitro. demonstrate Spp2p <br /> PRP (pre-mRNA processing) gene products            required step RNA cleavage  <br /> identified required splicing mem-       action, spliceosome assembly. Spp2p associ- <br /> bers family putative ATP-dependent RNA heli-         ates spliceosome prior Prp2p binding cases, termed DEAD/H box proteins (Burgess et al.,           spliceosome appears released splice- <br /> 1990; Chen &amp; Lin, 1990; Dalbadie-McFarland &amp; Abel-           osome following ATP hydrolysis.  Prp2p son, 1990; Company et al., 1991; Schwer &amp; Guthrie,           Spp2p capable interacting phys- <br /> 1991). prototype family eukaryotic        ically. report protein factor translation initiation factor eIF4A hydrolyzes ATP      interacts functionally physically RNA- thought unwind secondary structure          dependent ATPase required pre-mRNA splicing. <br /> 5&apos; untranslated regions messenger RNAs (reviewed          suggest Spp2p associates Prp2p Merrick, 1992). Prp5p Prp28p contain DEAD         spliceosome promote activity Prp2p. <br /> box motif Prp2p, Prpl6p, Prp22p contain DEAH motif assigned dif- <br /> ferent subfamily (Schmid &amp; Linder, 1992).           RESULTS proteins contain consensus elements       high-copy suppressor temperature-sensitive DEAD/H family (Wassarman &amp; Steitz, 1991;              prp2 alleles encodes essential protein Spp2 <br /> Schmid &amp; Linder, 1992), Prp2p, Prpl6p, Prp22p proteins share additional sequence similarity         previously reported isolation high-copy sup- carboxy termini (Chen &amp; Lin, 1990; Company          pressor prp2 (originally known rna2) temperature- <br /> et al., 1991).                                               sensitive mutants  et al., 1987). gene, named <br />    Prp2 protein required RNA            SRN2 (suppressor rna2), suppresses temperature <br /> cleavage-ligation reaction. absence Prp2p, sta-    sensitivity vivo splicing defect differ- <br /> ble assembly spliceosome occurs (Yean &amp; Lin,          ent alleles prp2 present high-copy num- <br /> 1991). Purified Prp2p bind spliceosome.          ber plasmid. SRN2 bypass suppressor Subsequently, ATP hydrolysis required       does suppress null allele PRP2  et al., <br /> reaction occur Prp2p released splice-     1987). renamed gene SPP2, suppres- <br /> osome (Kim &amp; Lin, 1993; Teigelkamp et al., 1994).            sor prp2.  Prp2p associates transiently splice-             Previously, suppressor activity defined osome cleavage-ligation reaction. Prp2p     1.1-kb Hind III-Xho genomic DNA fragment.  demonstrated bind directly pre-           et al., 1987). <span id='am-63' about='obo:IMR_0001349' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001698'><span id='am-64' property="rdfs:label" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-65' property="rdfs:label" content="nucleotide" datatype="xsd:string"></span><span id='am-66' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-67' property="oboInOwl:hasDbXref" content="CHEBI:25608" datatype="xsd:string"></span><span id='am-68' property="oboInOwl:id" content="IMR:0001349" datatype="xsd:string"></span><span id='am-69' property="obo:IAO_0000115" content="A nucleotide consists of a nitrogen-containing base, a five-carbon sugar, and one or more phosphate groups. Nucleotides can carry chemical energy (e.g. ATP), form coenzymes (e.g. CoA), be used as specific signaling molecules (e.g. cAMP) in the cell. Nucleotides are the subunits of the nucleic acids. " datatype="xsd:string"></span><span id='am-70' property="oboInOwl:hasExactSynonym" content="nucleoside phosphate" datatype="xsd:string"></span>nucleotide</span> sequence fragment <br /> mRNA substrate (Teigelkamp et al., 1994). believed     contains open reading frame (ORF) encoding puta- RNA-dependent ATPase activity Prp2p        tive protein 185 amino acids (Fig. 1A). DNA hy- <br /> quired dynamic conformational                bridizes 700-nt poly + mRNA (data shown), <br /> changes spliceosome critical      consistent length SPP2 ORF (185  <br /> mation catalytic core. support     dons). SPP2 predic,ted encode extremely hydro- <br /> changes snRNA-snRNA snRNA-pre-mRNA                 philic basic protein (pl = 8.35). <br /> teractions known occur point  Nilsen,        constructed GST-SPP2 fusion places 1994 references .  precise li-       entire coding sequence Spp2p frame gands effectors Prp2p identified.       amino terminus bacterial protein <span id='am-19' about='obo:IMR_0100173' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001700'><span id='am-20' property="rdfs:label" content="Reduced glutathione" datatype="xsd:string"></span><span id='am-21' property="oboInOwl:hasExactSynonym" content="5-L-Glutamyl-L-cysteinylglycine" datatype="xsd:string"></span><span id='am-22' property="oboInOwl:hasExactSynonym" content="Reduced glutathione" datatype="xsd:string"></span><span id='am-23' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-24' property="obo:IAO_0000115" content="A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides." datatype="xsd:string"></span><span id='am-25' property="rdfs:label" content="L-Glutathione" datatype="xsd:string"></span><span id='am-26' property="oboInOwl:hasExactSynonym" content="L-Glutathione" datatype="xsd:string"></span><span id='am-27' property="rdfs:label" content="glutathione" datatype="xsd:string"></span><span id='am-28' property="rdfs:label" content="5-L-Glutamyl-L-cysteinylglycine" datatype="xsd:string"></span><span id='am-29' property="oboInOwl:id" content="IMR:0100173" datatype="xsd:string"></span><span id='am-30' property="oboInOwl:hasDbXref" content="KEGG:C00051" datatype="xsd:string"></span>glutathione</span>-S- <br />    Purified Prp2p RNA-dependent ATPase,            transferase. GST-Spp2 fusion protein purified RNA helicase activity vitro (Kim et al., 1992).    Escherichia coli used generate rabbit poly- proteins belonging DEAD/H fam-            clonal antiserum specifically recognizes 26-kDa <br /> ily RNA-dependent ATPases,           protein yeast expressing SPP2 high-copy eIF4A human p68 protein, dem-           number plasmid (Fig. 1B). observed molecular <br /> onstrated possess RNA helicase activity           weight Spp2p reasonable agreement (Hirling et al., 1989; Rozen et al., 1990).    size SPP2 ORF. <br /> speculated proteins helicases,         order determine SPP2 essential require presence factors specific       gene,   replaced copy wild-type SPP2 gene <br /> substrates (Wassarman &amp; Steitz, 1991; Schmid &amp;               deletion-insertion aRele spp2Al::LEU2,  Spp2p required splicing reaction                                                                                                                        377 <br />            Hindlll <br />          5 &apos;Agct.tgcattactgaccatagtacatgtgcaagttattctaactaagaattacaga                                           60 <br />                                                                                                                                B~~~ <br />               gcttcatttgtcacagtcagttgatactactatgcttctaatgcttctaatatttatgca                                        120 <br />              ttgcaggttcaacatgacacttgggttctcaatgatctggcgctatcatttgttacc og                                         180 <br />  <br />  <br />              ccgtgcgtagaaaaaaatgtaaaaatataggaatagctgttttaagttattgaagtaata                                         240                    m    &gt;%         0    &gt;% <br />                                                            ThaI                                                                          0    O          o0 <br />              atgcacgtcagaqcgatggtaggtaaaatgtctagaggcatatctagatgtagaatgagc                                         300 <br />  <br />  <br />              aaottttcacttaaattggggagtaaacct                           cttmantatttccaag                aac <br />                                                                                                           KS        2 <br />  <br />                                                                                                                   360 <br />                                                                                                                                          m <br />                                                                                                                                          cm <br />                                                                                                                                               o:3   .&apos;m <br />                                                                                                                                                     -. <br />                                                                                                                                                               o <br />              K   F   S   L     R   L      G   S     T    L     K    KC N S K R                   T   IC       22             94- <br />              aaaaaaaactcattacagaaggccaacttattcgattgggatgatcggaaactg4caac                                          420 <br />              K   K   N   S     L   Q K          N    L 7        D       U D D              T      S        42 <br />  <br />              ctttogcataaacctcaaagtaagataaagattcaaagtattgataaattcgatcttgat                                         480 <br />                                                                                                                                   67- <br />              L   S   H   IC    P   Q S K K Q S D KC F 1D L D                                                 62 <br />                                                                                                      .A__                         43- <br />                                                                                                                                   30- <br />              gaagaatcatcttctggaggaaaattaatgatcaagctgagtgaaaatgcggataccaaa <br />              E   E   S   S     S   G      G K     L    V      K         L     S    N       D    T   K <br />                                                                                                                   540 <br />                                                                                                                    82                                              -*-Spp2p <br />              -------------------------------------                                                                                20- <br />              aaaaacgatgctcctctggtggaatatgtcaccgaaaagaatataatgaggtacctgtc <br />              K N     D       P   L      V   E   Y V T         EIK E <br />                                                                                        N   V      P   V <br />                                                                                                                   600 <br />                                                                                                                   102 <br />                                                                                                                                   14- <br />                      a__----------- <br />                           4&apos;                                          &apos; <br />              gaggaatttggagatgctttacttcggggtatggggtgggaaagtgactccgagcaagat                                         660 <br />                                                                                                                                          1     2         3 4 <br />              E   E   F G       D        L   L   R    G   K    G N E                S   D   S      Q   D       122 <br />                          (app2-1)                                                                                                     preimmune <br />                                                                                                                                          serum <br />                                                                                                                                                          immune <br />                                                                                                                                                          serum <br />              tctaaaggcgacaagacacagagtcgaaacaaggacgtttcaaatgtttcacagatacat 720 <br />              S   K   G   D     K   T Q        S   R    N   K    D V             S    N V     S   Q      H       142 <br />  <br />              cttgatggactgggaattgttgccaagttaaataaggcaataaacgtggagaggcttca                                          780 <br />                    (:LGIV <br />                  L D                            K               C                      VEEA <br />                                                                                           ET 9          S        6 <br />                                                                                                                   162 <br />  <br />  <br />                                           ClaI <br />  <br />              tttatgcccgtcgtaaaaatcgataaaataacgggcactaaagttgatgacgacaaaaaa <br />              F <br />                                                                                                                   840 <br />                      P   V     V   K        D   K      T    G         T     K    V   D   D   DK       K       182 <br />  <br />              aataagrcatgagaaagtttgaatatataatttaaagtacttggtatatacacattatat                                         900 <br />              N   K   S   *                                                                                        185 <br />              ttta tgc atg t tccraagstat tt ttag t ttggcttt tt tttcttat t tt ttcttcaat t                           960 <br />              tacttgataaatgaaatgcaaggaagttcagtttgatattatataagcaatagtcaaagg 1020 <br />                                    ThoI <br />               atggcaccaaacccctcgag 3&apos;                                         1040 <br />  <br />          FIGURE 1.  SPP2 contains 185-codon open reading frame. nucleotide sequence Hind III-Xho genomic DNA <br />          fragment capable suppressing prp2-1 depicted. sequence encodes putative protein 185 amino acids. spp2-1 <br />          mutation (G  changes <span id='am-71' about='obo:IMR_0100118' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001695 obo:IMR_0000001 obo:IMR_0100116'><span id='am-72' property="oboInOwl:hasDbXref" content="KEGG:C00037" datatype="xsd:string"></span><span id='am-73' property="oboInOwl:hasAlternativeId" content="IMR:0200057" datatype="xsd:string"></span><span id='am-74' property="oboInOwl:hasExactSynonym" content="Gly" datatype="xsd:string"></span><span id='am-75' property="rdfs:label" content="Gly" datatype="xsd:string"></span><span id='am-76' property="rdfs:label" content="Glycine" datatype="xsd:string"></span><span id='am-77' property="oboInOwl:hasExactSynonym" content="Glycine" datatype="xsd:string"></span><span id='am-78' property="rdfs:label" content="glycine" datatype="xsd:string"></span><span id='am-79' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-80' property="oboInOwl:hasExactSynonym" content="Aminoacetic acid" datatype="xsd:string"></span><span id='am-81' property="oboInOwl:id" content="IMR:0100118" datatype="xsd:string"></span><span id='am-82' property="rdfs:label" content="Aminoacetic acid" datatype="xsd:string"></span>Gly</span> 106 Glu. Codons removed construction deletion-insertion allele spp2M1::LEU2 <br />          indicated. B: Spp2 detected 26-kDa polypeptide. Cell extracts yeast strain JWY32 expressing SPP2          centromeric plasmid (lanes 2, 4) strain JWY36 expressing SPP2 GAL1-SPP2 allele (lanes 1, 3) analyzed          western immunoblot analysis using preimmune serum immune serum GST-Spp2 fusion protein. <br />  <br />  <br />  <br />  <br /> diploid yeast strain JWY749. resulting diploid                                                         Transcription GAL1-SPP2 allele induced sporulated meiotic products separated                                                               galactose-containing medium repressed glucose- <br /> tetrad dissection. viable spores                                                          containing medium. SPP2 mRNA expressed recovered tetrad (data shown).                                                         GAL1-SPP2 allele present high levels strain <br /> viable spores leucine auxotrophs, indicating                                                         JWY32 maintained galactose medium (Fig. 2B, contained wild-type allele SPP2                                                        lane 4). Thirty minutes shifting glucose-contain- <br /> spp2A1::LEU2. lethality spp2Al::LEU2 null                                                          ing medium, SPP2 mRNA undetectable (data allele complemented plasmid borne wild-                                                            shown), indicating transcription GALl- <br /> type allele SPP2 (data shown). Using condi-                                                           SPP2 allele shut glucose medium. <br /> tional allele SPP2, SPP2                                                             GAL1-SPP2 allele fully functional simply required spore germination, mitotic                                                         complement lethality spp2AI::LEU2 null allele. <br /> growth.                                                                                                        rate growth strain JWY32 (spp2A1::LEU2 + <br />                                                                                                                pGALl-SPP2) galactose-containing medium  <br /> SPP2 required pre-mRNA processing vivo                                                               distinguishable strain JWY36 (spp2Al::LEU2 + <br />                                                                                                                pYCp5O-SPP2), expresses wild-type SPP2 determine Spp2p itself required pre-                                                         allele. shifting glucose-containing medium, <br /> mRNA processing vivo, constructed yeast strain                                                           strain JWVY32 continues grow logarithmically 15 h, <br /> JWY32 (spp2AM::LEU2 + pGALI-SPP2), dependent                                                                rate growth begins decrease galactose synthesis Spp2p, assayed ef-                                                          completely ceases 50 h (Fig. 2A). rate fects depletion Spp2p pre-mRNA splicing.                                                              growth strain JWY36 unchanged 50 h glu- <br />  378                                                                                                                               J. Roy et al.        5 <br />                                                                                     (Fig. 2B). ACTI CRYI pre-mRNA detected <br />                                                                                     strains JWY32 JWY36 maintained          4                                                                          galactose medium (lanes 1, 4). hours shift- <br />  EC_                                                                                ing strain JWY32 glucose medium, concomitant  0 <br />          3                                                                          decrease growth rate, ACTI CRY1 pre- <br />                                                                                  mRNA began accumulate continued accumu- <br />   Cta <br />       2                                                                             late 28 h glucose medium (lanes 6-9); ratio <br />  0                                                                                  unspliced pre-mRNA spliced mRNA increased  0cm 1 <br />                                                                                     glucose medium growth rate strain  <br />     i0 <br />          0                                                                          creased. conditions, intron-lariat 3&apos; <br />                                                 o JWY36 (SPP2)                      exon splicing intermediate accumulated.  Spp2p <br />          -1                                     * JWY32 (GAL 1-SPP2)                necessary efficient pre-mRNA splicing vivo                                                                                _j   step steps prior concomitant                        10         20          30        40                     50   cleavage reaction splicing. <br />                      Time (hr) shift glucose medium <br />                                                                                     spp2 Temperature-sensitive mutants accumulate <br />                                                                                     pre-mRNA vivo <br />   B           YCpOSPP2 YCp5-GAL-SPP2                                                order investigate function Spp2p                gal    glu gal             glu                                        generated temperature-sensitive alleles                       -   -      <br />                                   <br />                                     s <br />                                      %. <br />                                       s <br />                                            N.   N-    N.                            SPP2 vitro mutagenesis. recessive, temperature- <br />                      0 0        0 uo                 c0                             sensitive alleles SPP2 obtained (M1-M6). Yeast <br />                                                                                     strains expressing alleles SPP2 centro- <br />                                                            -   ACT1 pre-mRNA <br />                                                                                     meric plasmids (spp2Al::LEU2 + pMl-6) unable                                                            -   ACTl mRNA            maintain growth 39 &#194;&#176;C compared strain JWY36 <br />                                                                                     (spp2Al::LEU2 + YCp5O-SPP2) expressing wild-type <br />                                                            -   CRY1 pre-mRNA        SPP2 (Fig. 3A). Northern blot analysis RNA ex- <br />                                                                                     tracted temperature-sensitive strains grown <br />                                                            -   CRY1 mRNA            permissive temperature shifting                                                                                     nonpermissive temperature, indicated CRYI pre- <br />                                                                                     mRNA accumulated vivo (Fig. 3B, data shown). <br />                                                            -   SPP2 mRNA            pre-mRNA detected permissive tem- <br />                                                                                     perature.  ratio pre-mRNA mRNA <br />                 1 2 3 4 5 6 7 8 9                                                   greatly increased 39 &apos;C. results  <br /> FIGURE 2. Depletion Spp2p results cessation growth ac-                 sistent Spp2p required step cumulation unspliced pre-mRNAs.  Strains grown ga-                     splicing vivo indicate mutant <br /> <span id='am-7' about='obo:IMR_0200277' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-8' property="oboInOwl:hasDbXref" content="KEGG:C00243" datatype="xsd:string"></span><span id='am-9' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-10' property="rdfs:label" content="Lactose" datatype="xsd:string"></span><span id='am-11' property="oboInOwl:id" content="IMR:0200277" datatype="xsd:string"></span>lactose</span> medium shifted glucose medium  indicated                   alleles SPP2 somewhat defective permis- <br /> arrows). Optical density 610 nm monitored. Cultures di-                 sive temperature, defect exaggerated luted periodically fresh medium maintain logarithmic growth optical density obtained multiplied corresponding                nonpermissive temperature. <br /> dilution factor. rate growth strain JWY32 (spp2Al::LEU2 +                    mutations responsible phenotypes YCp5O-SPP2) remains unchanged glucose medium,                        plasmid-bome M1-M6 alleles SPP2 determined <br /> rate growth strain JWY36 (spp2A1::LEU2 +pGALI-SPP2 )  <br /> gins decrease generations (15 h, indicated arrow)              DNA sequencing. M2 M3 mutant alleles <br /> ceases completely 45 h. B: RNA extracted strains grown                  identical contain single G transition galactose medium different times shift glucose  <br /> dium hybridized ACT1 CRYI DNA probes   SPP2                     changes Gly 106 Glu (Fig. 1A). M4, M5, M6 <br /> DNA probe  .                                                                 alleles contain mutation addition                                                                                     mutations. Ml allele contains different muta- <br />                                                                                     tions. M2 mutant allele used sub- <br /> cose  medium. infer delayed decrease                                sequent analysis henceforth referred spp2-1. <br /> growth rate strain JWY32 glucose medium results overproduction Spp2p galactose-grown <br /> cells, cessation growth does occur  <br />                                                                                     spp2-1 mutant extract blocked step <br /> til subsequent dilution Spp2p, following cell                            splicing vitro <br /> divisions glucose medium.                                                        Temperature-sensitive mutations 30 yeast <br />   assess effect depletion Spp2p pre-                                genes identified define trans-acting <br /> mRNA splicing, assayed amounts unspliced                                  factors required splicing (reviewed Rymond &amp; <br /> ACTI CRY1 pre-mRNA spliced ACTI CRY1                                    Rosbash, 1992; Hodges et al., 1993). cases, <br /> mRNA various times shift carbon source                              demonstration temperature sensitivity mutant <br />  Spp2p required splicing reaction                                                                                                                                  379 <br />  <br />                                                                                               <span id='am-31' about='obo:IMR_0001350' typeof='owl:Thing obo:IMR_0001650 obo:IMR_0001356 obo:IMR_0000947 obo:IMR_0001348 obo:IMR_0001382 obo:IMR_0000001 obo:IMR_0001384 obo:IMR_0001362'><span id='am-32' property="rdfs:label" content="1-Phosphatidyl-D-myo-inositol 4,5-bisphosphate" datatype="xsd:string"></span><span id='am-33' property="oboInOwl:hasAlternativeId" content="IMR:0200477" datatype="xsd:string"></span><span id='am-34' property="rdfs:label" content="Phosphatidyl-myo-inositol 4,5-bisphosphate" datatype="xsd:string"></span><span id='am-35' property="rdfs:label" content="1-Phosphatidyl-1D-myo-inositol 4,5-bisphosphate" datatype="xsd:string"></span><span id='am-36' property="oboInOwl:hasExactSynonym" content="phosphatidylinositol diphosphate" datatype="xsd:string"></span><span id='am-37' property="rdfs:label" content="PIP2" datatype="xsd:string"></span><span id='am-38' property="rdfs:label" content="phosphatidylinositol bisphosphate" datatype="xsd:string"></span><span id='am-39' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-40' property="obo:IAO_0000115" content="PI(4,5)P2 is cleaved by phospholipase C-beta or gamma to generate IP3 and diacylglycerol." datatype="xsd:string"></span><span id='am-41' property="oboInOwl:hasExactSynonym" content="Phosphatidyl-myo-inositol 4,5-bisphosphate" datatype="xsd:string"></span><span id='am-42' property="rdfs:label" content="phosphatidylinositol diphosphate" datatype="xsd:string"></span><span id='am-43' property="rdfs:label" content="Phosphatidylinositol-4,5-bisphosphate" datatype="xsd:string"></span><span id='am-44' property="oboInOwl:hasDbXref" content="KEGG:C04637" datatype="xsd:string"></span><span id='am-45' property="oboInOwl:hasExactSynonym" content="phosphatidylinositol bisphosphate" datatype="xsd:string"></span><span id='am-46' property="rdfs:label" content="PI(4,5)P2" datatype="xsd:string"></span><span id='am-47' property="oboInOwl:hasExactSynonym" content="1-Phosphatidyl-D-myo-inositol 4,5-bisphosphate" datatype="xsd:string"></span><span id='am-48' property="oboInOwl:hasExactSynonym" content="PIP2" datatype="xsd:string"></span><span id='am-49' property="oboInOwl:hasExactSynonym" content="Phosphatidylinositol-4,5-bisphosphate" datatype="xsd:string"></span><span id='am-50' property="oboInOwl:id" content="IMR:0001350" datatype="xsd:string"></span><span id='am-51' property="oboInOwl:hasExactSynonym" content="1-Phosphatidyl-1D-myo-inositol 4,5-bisphosphate" datatype="xsd:string"></span>pip2</span>-1                    spp2-1        wild-type <br />                                                                                              r-                       1                   F- 1 <br />                                                                              ATP             - + + +                    - + + +                -   + <br />                                                                        Time (min)            30 0 10 30                 30 0 1030           3030 <br />              23&#194;&#176;C                   39C <br />                                     WarT Ul M2 MR                                                                                                          CL_ <br />  <br />                                                                                                                                                            CL <br />  <br />                                                                                                                                                            U- <br />  <br />  <br />  <br />  <br />        B <br />              WT       M2                                                                     1 2 3 4                    5 6 7 8                9 10 <br />  <br /> Time (min)   30 60    30 60                                              B                       prp2-1                                   spp2-1 <br /> Temp (&#194;&#176;C) 23 39 39 23 39 39 <br />                                                                            ATP           - <br />                                                                                              F---~~~~~~~~~~~ <br />                                                                                                   +    +   +       +                 +     +       +       + <br />  <br />  <br />                                                                      Time (min)          30 0 10 20 30                         30    0 10 20 30 <br />                                           - CRY1 pre-mRNA <br />                                           - CRYl mRNA <br />                                                                                                                                                                                                                                                                                                                                                 |* B <br />  <br />  <br /> FIGURE 3. Temperature-sensitive spp2 mutants accumulate pre- <br /> mRNA vivo.  Growth wild-type strain JWY32 spp2                                                                                                           uX <br /> mutant strain containing M2 mutant allele spp2,  <br /> missive temperature (23 &#194;&#176;C) nonpermissive temperature (39 &#194;&#176;C) depicted. B: RNA extracted strains 23 &#194;&#176;C 30 min 60 min shifting 39 &#194;&#176;C hybridized CRYI <br /> DNA probe. <br />                                                                                      1        2       3    4        5          6     7     8       9       10 <br />  <br />                                                                         C <br />                                                                                                       prp2-1                               spp2-1 <br /> alleles vitro used suggest direct role                                                                              +0+ <br />                                                                                                                                                                    -                                                                            ATP           -        +    +   + + +                                       +       +    + <br />  gene product splicing (Lustig et al., 1986).            Time(min)       30 0              5   10      20 30           30 0        5   10 20 30 <br /> termine Spp2p directly required step splicing, assayed spp2-1 mutant extract splicing activity vitro. assayed splic- <br />                                                                                                                                                                               4I <br /> ing activity prp2-1 mutant extract. presence                                                                                                                            x1 ATP radiolabeled ACTI pre-mRNA substrate, wild-type extract able carry sec- <br /> ond cleavage ligation reactions vitro (Fig. 4A, <br /> lanes 9, 10). intron-lariat 3&apos; exon splicing <br /> intermediate mature mRNA detected spp2-1 prp2-1 extracts incubation pre- <br />                                                                                                                                                                                    ]X <br /> mRNA substrate 30 min (Fig. 4A).  spp2-1 blocked prior cleavage reaction vitro                         1 2 3 4 5 6                7 8 9 10 11 12 previously demonstrated prp2-1 (Lustig                  FIGURE 4. spp2-1 extract assembles spliceosomal complexes, et al., 1986). heat inactivation extract             unable carry catalytic reaction. cell extracts <br />                                                                      prepared wild-type strain (BJ2168), spp2-1 strain (JWY40), quired mutant phenotype. consistent                 prp2-1 strain (JWY667) incubated radiolabeled ACTI pre- fact spp2-1 mutant accumulates pre-                mRNA standard splicing conditions 18 &#194;&#176;C presence <br />                                                                      absence ATP indicated times. heat treatment mRNA permissive temperature vivo                  spp2-1 prp2-1 extracts carried subsequent somewhat defective permissive                 experiments.  pre-mRNA precursor, splicing intermediates, <br /> ditions  . postulate defect                products analyzed <span id='am-88' about='obo:IMR_0200111' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-89' property="oboInOwl:id" content="IMR:0200111" datatype="xsd:string"></span><span id='am-90' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-91' property="oboInOwl:hasDbXref" content="KEGG:C00086" datatype="xsd:string"></span><span id='am-92' property="rdfs:label" content="Urea" datatype="xsd:string"></span>urea</span>-acrlyamide gels. *-m , pre- pronounced vitro, experi-                   mRNA;            lariat-intron 3&apos; exon intermediate; <br />                                                                                   o-cj,                                              mature                        m    , <br />  <br />  <br />  <br />  <br />                                                                      mRNA; oX intron-lariat. B,C: Splicing complexes assembled                                                                                          , <br />  <br /> ments observed small ma-                    extracts analyzed native gel electrophoresis. B, ra- <br /> ture mRNA produced spp2-1 extracts                     dioactive band represents gel. <br />  380                                                                                                         J. Roy et al. <br /> absence heat inactivation.          carried vitro complementation spp2-1 <br /> defect spp2-1 extract specifically       extract extracts prepared temperature- <br /> fect Spp2 protein.                                      sensitive prp mutant strains prp3, prp16, prp18, <br />    Extracts prepared prp2 mutant alleles           extract prepared strain carrying able carry cleavage reaction ca-      temperature-sensitive snrl4 allele, encodes pable forming spliceosomal complexes vitro (Yean         U4 snRNA. cases, complementation ob- <br /> &amp; Lin, 1991; Plumpton et al., 1994; Teigelkamp et al.,         served spp2-1 extract (Fig. 5A, lanes 3-7 1994). assayed spp2-1 extract able          data shown). minor differences degree assemble spliceosomal complexes different            complementation attributed fact types native gel electrophoresis (Fig. 4B,C).          complementing extracts contain different amounts <br /> prp2-1 spp2-1 extracts able form splicing          complementing protein factor. spp2-1 extract <br /> specific complexes B presence ATP              efficiently complemented micrococcal <br /> (Fig. 4B). Complex B  referred pre-splice-      nuclease treated wild-type extract (Fig. 5A, lanes 5, 7, <br /> osome) described Cheng Abelson                 12) demonstrating defect spp2-1 ex- <br /> (1987). formation followed formation com-         tract lack RNA product.  <br /> plex  corresponds spliceosomal com-             prp2-1 extract efficiently complemented spp2-1 <br /> plexes Al A2-1 (Cheng &amp; Abelson, 1987).                extract (Fig. 5B). result suggests Prp2p complexes marked X formed nonspecifically           Spp2p act independently  e., represent commitment complexes (Cheng &amp; Abel-               tightly associated outside son, 1987); formation ATP independent.            spliceosome. Results confirm hypothesis. <br /> trace amounts complex B formed absence               attempted specifically complement defect <br /> exogenously added ATP extracts (lanes 1, 6)           spp2-1 extract addition wild-type Spp2 attributed endogenous ATP present           protein. used GST-Spp2 fusion protein,  <br /> extracts. Native agarose-polyacrylamide gel electropho-        scribed  experiments. Addition GST- <br /> resis (Pikielney et al., 1986) used determine      Spp2p spp2-1 extract efficiently complemented prp2-1 extract forms splicing-specific complexes         splicing defect (Fig. 5C, lanes 3-6), addi- III complex II (Fig. 4C, lanes 1-6)         tion unrelated GST-rp59 fusion protein previously demonstrated (Plumpton et al., 1994;           effect (lanes 7, 8). GST-Spp2 protein able <br /> Teigelkamp et al., 1994). Complex III precursor        complement prp2-1 extract (lanes 9, 10). <br /> complex  Complex represents spliceosome <br /> formed just prior step, complex II        Spliceosomal complexes formed spp2-1 <br /> contains splicing intermediates products (Pikielney        extract functional <br /> et al., 1986). spp2-1 extract formed complex effi- <br /> ciently, complex II detected (Fig. 4C, lanes        shown spp2-1 extract able 7-12). complex III detected spp2-1         form spliceosomal complexes vitro, unable extract.  30 min, prp2-1 extract forms       carry cleavage reaction. addition complex IH spp2-1 extract (compare lanes         GST-Spp2 fusion protein extracts, 6, 12), indicating kinetics complex formation      second steps splicing efficiently carried  slower prp2-1 extract spp2-1 ex-        possible ways fusion pro- <br /> tract. apparent Figure 4B,       tein complement spp2-1 extract. possi- <br /> version complex B complex slower             bility spliceosomal complexes formed prp2-1 extract. difference spp2-1         mutant extracts functional  lack wild- <br /> prp2-1 extracts likely result qualitative differ-   type Spp2p, undergo cleavage reaction. <br /> ences extract preparation differ-          presence GST-Spp2p, reaction ini- <br /> ences functions proteins. results          tiated. second possibility spp2-1 extract spp2-1 extract assembles spliceosomal            forms aberrant complexes, fusion protein complexes similar prp2-1 extract suggests           required formation functional complexes. proteins, Spp2p Prp2p, required           distinguish possibilities, carried step splicing, e., formation    experiment spp2-1 extract allowed <br /> spliceosomal complexes, cleavage          form spliceosomal complexes presence reaction.                                                      radiolabeled pre-mRNA substrate. 30 min,                                                                complexes &quot;chased&quot; excess unlabeled spp2-1 splicing defect complemented <br />                                                                pre-mRNA presence GST-Spp2p (Fig. 6). vitro GST-Spp2 fusion protein <br />                                                                Addition 50-fold, 100-fold, 200-fold excess  <br />                                                                labeled pre-mRNA did affect ability GST- order defect spp2-1 extract      Spp2p complement spp2-1 extract (lanes 6-8). specificaRy lack function protein factor,   control, showed 200-fold excess unlabeled <br />  Spp2p required splicing reaction                                                                                                     381 <br />  <br />                                                                      B                                      C <br />                                                                                                                                                 0 <br />  <br />                                                                                                     GST-rp59p(ng)         -   -- <br />  <br />                                                                                                                                                           ~0 <br />                     , <br />                          q_E    2+                                                                      GST-spp2p(ng)     -   -   &#194;&#176;    &#194;&#176;&#194;&#176;   -                                                                                  extract <br /> extract   g                          L:3EL    c                                                                   extract <br />                                                                              ATP     -   + - + + <br />   ATP     -    +    + + +       +     + + +   + +                                                                   ATP     -   + ++          +   + + + <br />                                                                  Q4M <br />                                                                  0a <br />  <br />                                                                                                                        0C <br />  <br />                                                                                                                     _- <br />                                                                                                        = <br />  <br />  <br />  <br />  <br />                                                                                                                                               7 5 Y 11 <br />               1 2       3 4 5 6 7     8 9 1011 12        13 14 <br />                                                                                      1   2 3   4 <br />  <br />           FIGURE 5. vitro complementation splicing defect spp2-1. splicing reactions carried 30 min           18 &apos;C.  Splicing reactions containing spp2-1 extract incubated absence presence ATP (lanes 1, 2), mixed <br />           equal volumes heat-inactivated prp16 extract (lane 3), heat-inactivated prpl8 extract (lane 4), wild-type extract mock- <br />           treated micrococcal nuclease (lane 5), heat-inactivated snR14 extract (lane 6), wild-type extract treated mi- <br />           crococcal nuclease (lane 7) presence ATP. lanes 8-14, splicing reactions containing extracts <br />           analyzed separately. B: vitro complementation spp2-1 prp2-1 extracts. Complementation carried            C: GST-Spp2 fusion protein GST-rp59 fusion protein used complementation spp2-1 prp2-1 ex- <br />           tract, indicated. <br />  <br />  <br />  <br /> pre-mRNA efficiently competed radiolabeled                              absence ATP, intermediates products pre-mRNA standard splicing reaction containing                              observed (Fig. 7, lane 1). demonstrates ATP <br /> wild-type extract (lanes 1-3). results demonstrate                         successfully depleted spliceosome assembly spliceosomal complexes formed spp2-1                             spp2-1 extract. Furthermore, splicing ob- <br /> extract, absence GST-Spp2p, functional.                            served GST-Spp2p added absence suggest Spp2p required                             ATP (Fig. 7, lane 2).  presence of steps leading stable spliceosome assembly                          ATP, fusion protein fully complement required step prior deavage reaction.                      spp2-1 extract (lane 3). control, showed <br />                                                                                  splicing occurred addition heat-inactivated <br /> Spp2p required prior ATP hydrolysis Prp2p                               prp3 mutant extract presence ATP (lane 4). <br />                                                                                  results demonstrate Spp2p function  <br /> ATP hydrolysis Prp2p required cleav-                         quired concomitant prior ATP hydrolysis <br /> age reaction (Kim &amp; Lin, 1993). Specifically,                        necessary initiate cleavage reaction. <br /> demonstrated purified spliceosomal complexes <br /> lacking Prp2p undergo cleavage reaction                            Spp2p associates spliceosome prior addition ATP Prp2p, Prp2p                               Prp2p binding cleavage reaction absence ATP (Kim &amp; Lin, 1993). shown Spp2p required steps                             Prp2 protein demonstrated associate <br /> fore concomitant initiation cleavage                        spliceosome prior cleavage reaction <br /> reaction. determine Spp2p functions                                (King &amp; Beggs, 1990; Kim &amp; Lin, 1993). Subsequent <br /> fore ATP hydrolysis, spp2-1 extract al-                         ATP hydrolysis Prp2p thought release pro- <br /> lowed assemble spliceosomal complexes. ATP                                tein spliceosome (Kim &amp; Lin, 1993; Teigel- depleted extract addition glu-                           kamp et al., 1994). Association Prp2p cose. ATP depletion occurs endogenous                                 spliceosome transient detected readily <br /> hexokinase activity extract (Horowitz &amp; Abelson,                          wild-type extracts, detected extracts 1993). Subsequently, extract &quot;chased&quot;                               dominant negative PRP2 strains protein GST-Spp2p presence absence ATP.                                unable dissociate spliceosome (Plumpton spp2-1 extract chased wild-type extract                          et al., 1994). sought determine Spp2p <br />  382                                                                                                             J. Roy et al. <br /> GST-Spp2p <br />  unlabeled                         x                     x x <br />                                    0                   x 0 0 <br />  pre-mRNA                          C04 <br />                                              _     _0 <br />                                                        LO <br />                                                             0    cCM <br />                                                V <br />                                              1rtfV-         V-   &quot; <br />                                                                                                             N CNI     C\JC\J <br />         extract <br />                               +5 +5 <br />            ATP <br />                                                                                    FIGURE 6. spp2-1 extract assembles <br />                                                                                    functional spliceosomes. Wild-type ex- <br />                                                                                    tract incubated radiolabeled <br />                                                                                    pre-mRNA standard splicing  <br />                                                                                    ditions  30 min 18 &apos;C) absence <br />                                                                                    presence ATP (lanes 1, 2)                                                                                    presence 200-fold excess unlabeled <br />                                                                                    pre-mRNA (lanes 1, 3). spp2-1 extract <br />                                                                                    incubated radiolabeled pre- <br />                                                                                    mRNA 30 min 18 &apos;C                                                                                    &quot;chased&quot; 50-fold (lane 6), 100-fold <br />                                                                                    (lane 7), 200-fold (lane 8) excess  <br />                                                                                    labeled pre-mRNA presence 50 ng <br />                                                                                    GST-Spp2 fusion protein ad- <br />                                                                                    ditional 30 min. Lanes 4 5 controls <br />                                                                                    demonstrate phenotype                                                                                    spp2-1 extract incubation radio- <br />                                                                                    labeled pre-mRNA. <br />  <br />  <br />  <br />  <br />                      1 2 3                 4 5 6 7 8 <br />  associates spliceosome promote          similar fraction pre-mRNA assemble splice- cleavage reaction (Fig. 8). Splicing reactions    osomes. demonstrates Spp2 protein asso- <br /> immunoprecipitated polyclonal antiserum            ciated spliceosome prp2-1 extract. Spp2p. conditions, Spp2 protein          inability detect association Spp2p immunoprecipitated antiserum (Fig. 8A).          spliceosome wild-type extract suggests  like <br /> RNA extracted immune pellet assayed         Prp2p, association Spp2p spliceosome presence pre-mRNA splicing intermediates       destabilized cleavage reaction. products. specific immunoprecipitation           order demonstrate Spp2p associate <br /> observed splicing reactions containing wild-type ex-      spliceosomes presence wild-type Prp2p, <br /> tract spp2-1 extract, presence absence       employed analogous ones used previ- <br /> ATP (Fig. 8B, lanes 14).  prp2-1 mu-          ously detect association Prp2p Prpl6p tant extract, pre-mRNA substrate immuno-          spliceosome (Schwer &amp; Guthrie, 1991; Kim &amp; Lin, <br /> precipitated Spp2p antiserum (Fig. 8B, lane 8).       1993; Teigelkamp et al., 1994). spp2-1 extract Quantification signal demonstrated approx-       allowed assemble spliceosomes absence imately 25% pre-mRNA immunoprecipi-               GST-Spp2 fusion protein. ATP depleted tated. believe represents significant fraction     extract described  GST-Spp2p added spliceosome-associated pre-mRNA. exam-            reactions presence absence ATP. <br /> ple, wild-type extract (lane 2), approximately        reactions used immunoprecipitation <br /> 20% pre-mRNA converted mature mRNA.             Spp2p antibodies (Fig. 8B, lanes 5-7).  Spp2p required splicing reaction                                                                                    383 <br />  <br />  <br />  <br />                                    0.                                      spp2-1 extract <br />                                                                                   +ATP <br />                                                                                   +labeled pre-mRNA <br />                                                                              complex  <br />  <br />                                                                              deplete ATP <br />  <br />  <br />                                                         + <br />                                                                              //+                          +                     + <br />  <br />                                                 wild-type GST-Spp2p GST-Spp2p Aprp3 <br />                                                       (1)                    (2)                          +                     + <br />  <br />                                                                                                    ATP        (3)         ATP       (4) <br />  <br />  <br />  <br />  <br />     1      2 3            4 <br />         FIGURE 7. Spp2p function required prior ATP hydrolysis cleavage reaction. Standard splicing reactions <br />         containing spp2-1 extract incubated 18 &#194;&#176;C 30 min followed ATP depletion. Reactions supple- <br />         mented wild-type extract absence ATP (lane 1), 50 ng GST-Spp2p absence ATP (lane 2), 50 ng         GST-Spp2p presence ATP (lane 3), heat-inactivated prp3 extract presence ATP (lane 4) allowed <br />         proceed additional 30 min. <br />  <br />  <br />  <br /> fusion protein added spp2-1 extract prior               independent Prp2p binding splice- radiolabeled pre-mRNA, association Spp2p                    osome.  Spp2p appears necessary spliceosome detected (lane 5).                   association Prp2p spliceosome; antibodies <br /> analogous wild-type extract confirms                Prp2p immunoprecipitate pre-mRNA <br /> ability detect association Spp2p wild-             spp2ts extract, GST-Spp2p <br /> type spliceosome. fusion protein added                   added  ATP) extract (S.-H. Kim &amp; spliceosome assembly absence ATP,                 R.-J. Lin, pers. comm.). reaction did place (lane 14).  conditions Spp2 protein associ-                   Evidence physical interaction Spp2p <br /> ated spliceosome (lane 6). addition                  Prp2p vivo <br /> ATP, splicing reaction occurred asso- <br /> ciation Spp2p spliceosome longer                   mechanisms suggested high- <br /> detected (lanes 7, 15). results Spp2p                 copy suppression prp2 alleles SPP2  et al., <br /> associates assembled spliceosome prior                1987). possibility Prp2p Spp2p inter- reaction.                                                       act physically pre-mRNA splic- <br />    spliceosomes formed prp2-1 mutant ex-                   ing. results support hypothesis.  tract contain Prp2 protein (King &amp; Beggs, 1990).               multicopy suppression reciprocal; temperature shown  able detect association                  sensitivity spp2 alleles partially suppressed Spp2p spliceosomes.  binding                       introducing extra copies PRP2 (Fig. 9A). spp2-1 <br /> Spp2p spliceosome appears place prior                  strain expressing PRP2 centromeric plasmid grows <br />  384                                                                                                                                            J. Roy et al. <br />  <br />  <br />  <br />                                                                                                                     &apos;p <br />  <br />  <br />  <br />                                                                                                                       t <br />                                                                                               IgG    - <br />                                                                                                                                     -43 kDa <br />                                                                                                                                     - 30 kDa <br />                                                                                           Spp2p -* <br />                                                                                             IgG -)                                  - 20 kDa <br />                                                                                                              1   2      3       4 <br />                      B <br />                                    anti-Spp2p <br />                                                                 GST-Spp2p-               ++ +                + <br />                                                                  +   +. <br />                                                                                                          sa2-1 xR <br />                                                                                                                  +ATP <br />                        ATP-+       -   + + -+ +       -    +1+       + + <br />                                                                                                                  +laballed pre-mRNA <br />                                                                                                           complex                                                                             0- <br />                                                                             rn-rn                        deplete ATP <br />  <br />                                                                              -        GST-S2p (14)                       GST-Spp2p <br />                                                                                               +                              ATP (15) <br />                                                                                     IP anti-Spp2p (6)                   + <br />                                                                                                                    lP anti-Spp2p (7) <br />                                 1 2 3 4 5 6 78        9 10111213141516 <br />  <br />         FIGURE 8. Spp2p associates spliceosome prior Prp2p binding released spliceosome following <br />         ATP hydrolysis. Splicing reactions immunoprecipitated preimmune serum anti-Spp2p antibodies bound         protein Sepharose.  Western blot analysis proteins immune pellets (lanes 1-3) cell extract yeast <br />         strain JWY32 expressing GALI-SPP2 (lane 4). B: Splicing reactions containing wild-type extract absence presence <br />         ATP (lanes 1, 2), spp2-1 extract absence presence ATP (lanes 3, 4), spp2-1 extract plus GST-Spp2p (lane 5), <br />         GST-Spp2p added spp2-1 extract ATP depletion (lane 6), GST-Spp2p ATP added spp2-1 extract         ATP depletion (lane 7), prp2-1 extract (lane 8) used immunoprecipitation. reactions carried 18 &#194;&#176;C <br />         30 min. Radiolabeled RNAs immune pellet analyzed urea-acrylamide gels. quarter splicing <br />         reactions removed prior addition antibodies analyzed separately (lanes 9-16). Lanes 9-16 exposed <br />         times longer lanes 1-8, visualize lariat intron product lariat intron -3&apos; exon splicing intermediate. <br />         diagram right explains reactions used lanes 6, 7, 14, 15. <br />  <br />  <br />  <br /> slightly 39 &#194;&#176;C compared control strain bearing                   scriptional activation GAL4(op)-lacZ reporter plasmid insert. PRP2 expressed                      interaction fusion pro- strain high-copy number plasmid, suppres-                     teins. SPP2-GAL4 DNA binding domain fusion <br /> sion temperature sensitivity spp2-1 increased.                able complement spp2Al::LEU2 null allele <br />    order demonstrate directly Prp2p                    (data shown). PRP2 fusion constructs <br /> Spp2p physically interact, used  hybrid&quot;                        able rescue temperature sensitivity (Fields &amp; Song, 1989). PRP2 SPP2                            prp2-1 mutant strain (data shown).  coding regions fused frame GAL 4                       Spp2p Prp2p fusion proteins functional. Taken <br /> DNA binding domain activation domain (Fig. 9B).                         results indicate Spp2p gene fusions expressed strain bear-                     Prp2p proteins capable interacting physically <br /> ing GAL4(op)-lacZ reporter. Strains expressing                      manner reflect roles fusions control plasmids white                       pre-mRNA splicing. X-GAL filter assay (Fig. 9B) background <br /> levels ,B-galactosidase activity (approximately 5 units                 DISCUSSION activity mg protein).  strains Prp2p fusions expressed                      characterized S. cerevisiae gene SPP2, complementary Spp2p fusion light blue color                        high-copy suppressor temperature-sensitive prp2 <br /> (Fig. 9B), approximately 20 units ,3-galac-                     mutant strains. reported previously extra cop- <br /> tosidase activity mg protein, indicating tran-                  ies SPP2 confer growth nonpermissive tem- <br />  Spp2p required splicing reaction                                                                               385 <br />  <br />                                                                         mediates products form                                                                           catalytic reaction. Like prp2-1 extract,                                                                           detect appearance splicing complex II                             SPP2FYCp50                                    spp2-1 extract.  spp2-1 extract defective                               YCp50                                       step converts complex complex II. <br />                             PRP2FYCp50                                       specifically rescue inability spp2-1 <br />                               YEp24 <br />                                                                           extract undergo cleavage reaction addi- <br />                             PRf2YEp24                                     tion Spp2 protein form GST-Spp2 fusion. <br />                               widtype                                     Furthermore, pre-mRNA contained <br />                                                                           splicing complexes formed spp2-1 extract <br />           23&#194;&#176;C                                        39&#194;&#176;C                chased products second <br />                                                                           reactions addition GST-Spp2 fusion protein. <br />                                                                           Based results, believe pheno- <br />                                     <br />                                    b                                      type spp2-1 extract SPP2 null mutant, <br />   B                                                                       e., spliceosomal complexes formed mu- <br />                                                                           tant extract absence protein                                                                           Spp2p trans-acting factor required splice- <br />                                                                           osome assembly. analogous phenotype <br />             pGDB                                                          prp2-1 mutant extract (Kim &amp; Lin, 1993).  <br />                                                                            rule possibility pres- <br />            pGDB-                                                          ence mutant protein required formation            PRP2 <br />                                                                           splicing complexes addition wild-type <br />            pGDB-                                                          protein, exchange occurs proteins <br />            SPP2 <br />                                                                           enabling spliceosome proceed  think <br />                                                                           unlikely detect associa- <br /> FIGURE 9. Spp2p Prp2p interact   Extra cop-         tion mutant protein complexes formed <br /> ies PRP2 partially suppress spp2-1 mutant strain. Yeast strain     spp2-1 extract  . <br /> JWY40 (spp2-1) transformed low-copy number (YCp5O)               complementation spp2-1 defect <br /> high-copy number (YEp24) plasmids bearing PRP2 vectors tested growth permissive (23 &#194;&#176;C) restrictive (39 &#194;&#176;C)   GST-Spp2p occurs prior concomitant ATP <br /> temperatures. B: Physical interaction Spp2p Prp2p          hydrolysis cleavage reaction. fusion <br /> detected GAL4  hybrid&quot;  Yeast strain GGY: :171          protein complement complexes formed containing (GAL4)op-LacZ reporter transformed plasmids <br /> containing PRP2 SPP2 fused GAL4 DNA binding domain              spp2-1 extract absence ATP. assume <br /> (GDB) GAL4 activation domain (GAD) vectors               hydrolysis catalyzed Prp2p, Transformants tested ,-galactosidase activity X-GAL        possible second, unidentified, ATP hy- <br /> filter assay. <br />                                                                           drolyzing protein function step. Pre- <br />                                                                           viously, Kim Lin (1993) shown gradient <br />                                                                           purified spliceosomes formed prp2-1 extract perature different prp2 temperature-sensitive                  undergo cleavage reaction addition strains, complement null allele PRP2                      purified Prp2p ATP. Addition Prp2p  <br />  et al., 1987). SPP2 essential                   sults binding Prp2p spliceosome, vegetative growth. majority yeast gene                     reaction occurs hydrolysis ATP. <br /> products required pre-mRNA processing essen-                      Spp2p required prior ATP hydrolysis, tial factors (Rymond &amp; Rosbash, 1992). demon-                          follows prp2-1 spliceosome contains <br /> strate SPP2 necessary pre-mRNA processing                     Spp2p, Spp2p function occurred protein required RNA                        prp2-1 spliceosome protein longer splice- <br /> cleavage-ligation reaction vivo.                                       osome associated. Spp2 protein    define function Spp2p precisely,                     specifically associated spliceosomes prp2-1 undertaken detailed characterization                        extract.  spliceosomes purified Kim temperature-sensitive spp2-1 mutant vitro. spp2-1                    Lin (1993) likely contained Spp2p. cell extract unable carry cleav-                   unable detect association Spp2p age reaction vitro.  extract able                 spliceosome wild-type conditions. semble stable spliceosomal complexes (complex                        case Prp2p Prpl6p, associate pre-mRNA substrate. Pikielny et al. (1986)                      transiently spliceosome (Schwer &amp; Guthrie, <br /> fined discrete complexes  II, III according                   1991; Teigelkamp et al., 1994). unable  increasing electrophoretic mobility. Complex III                  tect association Spp2p spliceosomes formed <br /> precursor complex formed prior                  spp2-1 extract. suggests mutant pro- <br /> cleavage reaction. Complex II contains splicing inter-                    tein unable associate spliceosomes,  386                                                                                                                    J. Roy et al. explanations possible. GST-                        experiments rule possibility Spp2p binds spliceosomes formed spp2-1                      Spp2p required second cleavage reaction <br /> extract absence ATP. addition ATP,                      released spliceosome  Future reaction occurs association GST-Spp2p                    experiments spliceosomes purified spliceosome longer detected. sug-                     spp2-1 extract, purified Spp2p, purified Prp2p gests Spp2p released spliceosome fol-                    address directly validity model. <br /> lowing ATP hydrolysis. Alternatively, ATP hydrolysis                         identified SPP2 genetic interaction result conformational changes render GST-                     PRP2. evidence  <br /> Spp2p inaccessible antibodies.                                     teraction; temperature-sensitive spp2 mutant strains   Based results results discussed                      suppressed extra copies PRP2. we propose model ordered association                     Spp2p Prp2p proteins capable physi- <br /> factors Spp2p Prp2p spliceosome (Fig. 10).                   cal interaction use  hybrid&quot;  <br /> Spp2p associates assembled spliceosome                      feel basis genetic interaction <br /> (complex , followed Prp2p binding. Binding                        direct physical association pro- proteins spliceosome ATP independent.                      teins association mediated protein. Subsequent ATP hydrolysis results cleavage                   unable detect association reaction (formation complex II) proteins                  proteins immunoprecipitation cell ex- <br /> simultaneously released spliceosome.                        tracts methods employed far (data spp2-1 extract, complex accumulates does                     shown). suggest association transient contain Spp2p Prp2p. prp2-1 extract,                    takes place assembled spliceosome. <br /> spliceosomal complex accumulates does contain                           function Spp2p splice- <br /> Spp2p. favor ordered addition                         osome? possibilities based  <br /> Spp2p Prp2p spliceosome, possible                   sults presented  Spp2p facilitate binding proteins simultaneously associate                        Prp2p spliceosome. Alternatively, Spp2p spliceosome strictly require presence                   required hydrolysis ATP Prp2p association. case,               putative helicase activity Prp2p. Spp2p expect detect binding Prp2p splice-                     required release Prp2p osomes purified spp2-1 extract. Furthermore,                     spliceosome. obviously mutually exclu- suggested Spp2p released                         sive possibilities. like speculate spliceosome cleavage reaction,                   Spp2p functions promote putative helicase ac- <br />  <br />  <br />     spp2-1 spliceosome                                     p.p2-1 spliceo  <br />  <br />                                        Vp                                            Prp2P. <br />  <br />  <br />            Complex                                                                                                     <span id='am-1' about='obo:IMR_0001360' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-2' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-3' property="oboInOwl:id" content="IMR:0001360" datatype="xsd:string"></span><span id='am-4' property="rdfs:label" content="ADP" datatype="xsd:string"></span><span id='am-5' property="oboInOwl:hasDbXref" content="KEGG:C00008" datatype="xsd:string"></span><span id='am-6' property="oboInOwl:hasAlternativeId" content="IMR:0200375" datatype="xsd:string"></span>ADP</span> <br />  <br /> FIGURE 10. model association Spp2p Prp2p spliceosome. Spp2p binds complex absence Prp2p ATP. followed Prp2p binding. Subsequent ATP hydrolysis <br />                                                                                   9+tei CADP <br /> leads fit catalytic reaction (Step 1) resulting formation complex U release proteins spliceosome. <br />                                                                                         Stepi1 <br />                                                                                                        Complex II <br />  Spp2p required splicing reaction                                                                             387 <br />  <br /> tivity Prp2p. base analogous situation          shown interact directly wild-type pre- translation initiation factors eIF4A eIF4B.          mRNA (Teigelkamp et al., 1994).  ex- <br /> eIF4A DEAD box helicase hydrolyzes ATP              periments, Teigelkamp et al. detect indirect binding <br /> unwind RNA secondary structure (Rozen et al., 1990;              Prp2p certain truncated versions pre- <br /> Jaramillo et al., 1991). helicase activity eIF4A       mRNA suggest interaction mediated greatly stimulated eIF4B (Rozen et al., 1990).            factors. possible Spp2p interacts <br /> eIF4B protein contains consensus RNA-binding motifs              pre-mRNA facilitates direct inter- <br /> (RRMs) binds RNA addition eIF4A                 action Prp2p pre-mRNA. Purified Prp2 <br /> (Grifo et al., 1984). proteins associate           protein does unwind RNAs vitro (Kim et al., <br /> RNA absence ATP. Subsequent ATP hydro-                 1992). Future experiments determine activ- <br /> lysis eIF4A releases proteins RNA               ity stimulated addition purified Spp2p <br /> (Grifo et al., 1984; Rozen et al., 1990). Recently, yeast        Gst-Spp2 fusion protein. <br /> eIF4B identified high-copy suppressor temperature-sensitive mutations eIF4A (Coppolec-              MATERIALS METHODS <br /> chia et al., 1993). <br />    Spp2p does contain discernible               Strains, plasmids, media <br /> RNA-binding motifs, highly basic hydro-              Yeast strains used study described Table 1. Tech- <br /> philic protein containing stretches lysine res-       niques growing yeast bacteria described <br /> idues. number RNA binding proteins                   (Sherman et al., 1986). Yeast transformed contain lysine-rich basic domains medi-            DNA lithium acetate method (Ito et al., 1983). <br /> ate RNA binding (Engebrecht &amp; Roeder, 1990; Siomi                  deletion disruption allele SPP2 constructed et al., 1993). determined Spp2p di-           codons 79-115 SPP2 open reading frame rectly binds pre-mRNA snRNA.                   replaced LEU2 gene. DNA fragment containing <br />                                                                  deletion-insertion allele (spp2A1::LEU2) used  <br /> sayed levels U4, U5, U6 snRNAs             place copy SPP2 diploid yeast strain JWY749 spp2-1 mutant vivo detect changes              homologous recombination (Rothstein, 1983) generate levels nonpermissive temperature (data           strain JWY28. haploid yeast JWY29 (spp2A1::LEU2 + shown). indicates structure U4, U5,         pTC3-SPP2) obtained transformation diploid <br /> U6 snRNPs, stability U4, U5, U6 snRNAs             JWY28 plasmid pTC3-SPP2, containing wild-type perturbed spp2-1 mutant, suggesting           SPP2 plasmid containingTRPl CEN3, followed Spp2p component snRNPs. Prp2p              sporulation random spore analysis. <br />  <br />  <br /> TABLE 1. Strains used. <br /> Strain            Genotype                                                                                  Source reference <br />  <br /> BJ2168            MATa gal2 leu2 pep4-3 prcl-407 prbl-l122 trpl ura3-52                                 E. Jones (1991) <br /> JWY749            MATa/MATa his3A200/his3A200 leu2A1/leu2Al lys2-801/lys2-801 trplA101/trplA01          J. Maddock, thesis (1990) <br />                   ura3-52/ura3-52 <br /> JWY28             MATa/MATa his3A200/his3A200 leu2M1/leu2Al lys2-801/lys2-801 trplA101/trplA01          study <br />                   ura3-52/ura3-52 spp2Al::LEU2/SPP2 <br /> JWY29             MATa his3A200 leu2Al lys2-801 trplA101 ura3-52 spp2A1::LEU2 + pTC3-SPP2               study <br /> JWY32             MATa his3A200 leu2Al lys2-801 trplA101 ura3-52 spp2A1::LEU2 + pGALI-SPP2              study <br /> JWY36             MATa his3A200 leu2Al lys2-801 trplAl01 ura3-52 spp2Al::LEU2 + YCp5O-SPP2              study <br /> JWY38             MATa his3A200 leu2A1 lys2-801 trplM101 ura3-52 spp2Al::LEU2 + pMl                     study <br /> JWY40             MATa his3A200 leu2Al lys2-801 trplA101 ura3-52 spp2Al::LEU2 + pM2 (spp2-1)            study <br /> JWY49             MATa his3A200 leu2Al lys2-801 trplA101 ura3-52 spp2Al::LEU2 + pM3                     study <br /> JWY51             MATa his3A200 leu2M1 lys2-801 trplAl01 ura3-52 spp2Al::LEU2 + pM4                     study <br /> JWY45             MATa his3A200 leu2A1 lys2-801 trplA101 ura3-52 spp2Al::LEU2 + pM5                     study <br /> JWY47             MATa his3A200 leu2A1 lys2-801 trplAl01 ura3-52 spp2Al::LEU2 + pM6                     study <br /> JWY667            MATa adel his7 leu2 lys2 prp2-1                                                       J. Maddock, thesis (1990) <br /> JWY2423           MATxi his3-11,15 Trp- Lys- ura3-52 snrl4ts                                            J. Roy, thesis (1995) <br /> JWY2405           MATa 4-51 Trp- Leu- Lys- ura3-52 prpl8ts                                          J. Roy, thesis (1995) <br /> JWY779            MATa 4-51 Trp- Lys- prpl6ts                                                       J. Maddock, thesis (1990) <br /> JWY630            MATa adel ade2 Gal- his7 lys2 tyrl ural prp3-1                                        J. Maddock, thesis (1990) <br /> GGY::171          Agal4 Agal80 his3 leu2 ura 3 (Gal4)op GALI-lacZ                                       C. Chien et al. (1991) <br />  388                                                                                                                 J. Roy et al. <br />    GAL1-SPP2 conditional allele constructed plac-       Johnson (1988) modification insoluble <br /> ing 750-bp Xba Xho fragment, containing coding        protein fraction partly solubilized 1.5% Sarkosyl, <br /> gion SPP2, downstream GALI promoter yeast           25 mM triethanolamine, 1 mM EDTA 10 min 4 &#194;&#176;C,  <br /> vector containing URA3 CEN4. construct, nucle-         sulting greater recovery fusion protein. prepa- <br /> otide -25 respect ATG SPP2 directly 3&apos;    ration active fusion protein, steps carried GALl transcription start site, transcription SPP2     4 &apos;C. Approximately 1.5 mg fusion protein shipped control GALl promoter. plasmid         Berkeley Antibody Company (Richmond, California) taining GAL1-SPP2 allele transformed yeast            generation rabbit polyclonal antisera. Crude antiserum strain JWY29. Strain JWY32 (spp2A1::LEU2 + pGALl-SPP2)             purified ammonium sulfate precipitations described derived transformants screening loss       Harlow Lane (1988). TRP1-marked pTC3-SPP2 plasmid. YCp5O-SPP2 <br /> plasmid contains 1.1-kb Hind III-Xho fragment SPP2 <br /> cloned YCp5O (ohnston &amp; Davis, 1984). Yeast strain JWY36        Nucleic acid electrophoresis, transfer, <br /> (spp2A1::LEU2 +YCp5O-SPP2) obtained transforma-             hybridization <br /> tion strain JWY29 YCp5O-SPP2, followed loss          methods used electrophoresis DNA RNA pTC3-SPP2 plasmid  Growth viability            nucleic acid transfer Nytran membranes (Schleicher &amp; <br /> yeast strains JWY32 JWY36 galactose medium          Schuell, Keene, New Hampshire) described Roy <br /> shifting glucose medium assayed described            et al. (1995). Radiolabeling DNA probes hybrid- <br /> Moritz et al. (1991).                                              ization Nytran membranes described    Temperature-sensitive alleles SPP2 obtained fol-     Moritz et al. (1991). 2.2-kb Hind III DNA fragment contain- <br /> lows. Single-stranded DNA templates, prepared phage-          ing CRYl gene used probe detect CRY1 pre- <br /> mid vectors containing SPP2, mutagenised vitro        mRNA mature mRNA. 2.2-kb EcoR Hind III DNA <br /> methoxylamine (McEachern et al., 1985). Mutagenized DNA            fragment containing ACT1 gene used probe containing complementary sequences encoding SPP2              ACTI pre-mRNA mature mRNA. Yeast poly  + RNA <br /> annealed cloned plasmid pRS313 (Hieter &amp; Sikor-           isolated described Couto et al. (1987). Probes ski, 1989) containing HIS3 CEN6. DNA extracted             snRNAs described previously (Roy et al., 1995). bacterial transformants, pooled, transformed yeast strain JWY36. thousand  trans- <br /> formants replica-plated medium containing 5-FOA            DNA sequence analysis select loss YCp5O-SPP2 plasmid. result- <br /> ing strains screened temperature sensitivity var-      1.1-kb Hind III-Xho fragment containing SPP2 se- <br /> ious temperatures. temperature-sensitive yeast strains         quenced follows. Subclones fragment were identified. mutant plasmids designated pMl-          restriction enzyme digestion Exonuclease HI/Mung <br /> pM6. pM2 plasmid contains mutant allele spp2-1.            bean nuclease digestion cloned phagemid vec- <br />    YCp5O-PRP2 plasmid (pRL31) YEp24-PRP2 plas-             tors pBluescript II KS&apos; SKI (Stratagene, La Jolla, Cali- <br /> mid (pRN2) described  et al., 1984,       fornia). Single-strand DNAs derived vectors 1987).                                                             used templates sequencing dideoxy chain- <br />    Fusions PRP2 SPP2 GAL4 DNA binding            termination method (Sanger et al., 1977), using Sequenase <br /> activation domains cloning entire coding          Version 2.0 (United States Biochemicals, Cleveland, Ohio). <br /> regions SPP2 PRP2 vectors pGAD2F                Double-stranded DNA prepared plasmids bearing <br /> pMA424 (Chien et al., 1991) codon       mutant alleles SPP2, denatured, sequenced SPP2- <br /> frame GAL4 activation domain DNA-binding              specific primers  <br /> domain, respectively. fusion constructs checked DNA sequencing transformed yeast strain              Preparation splicing extracts <br /> GGY::171 (Chien et al., 1991). <br />    Plate assays f-galactosidase activity       vitro analysis <br /> scribed Staudinger et al. (1993). ,B-galactosi-   Splicing extracts prepared yeast strains grown dase activity measured liquid culture described     30 &apos;C method Lin et al. (1985), modifica- Deshmukh et al. (1993). Units activity expressed      tion spheroplasted cells allowed regenerate <br /> (optical density minute x 1,000) microgram pro-         rich medium containing 1.2 M sorbitol 2 h 30 &apos;C prior <br /> tein (measured Bio-Rad assay kit) average       homogenization. Activity extracts checked independent transformants.                                   standard splicing reactions using ACTI pre-mRNA tran- <br />    GST-SPP2 fusion constructed cloning 600-bp         scribed vitro radiolabeled 32p (Lin et al., 1985). <br /> Xba Sca fragment containing SPP2 vector pGEX3X        Analysis splicing complexes formed spp2-1 prp2-1 <br /> (Pharmacia Biotech , Piscataway, New Jersey)         extracts carried described Arenas Abelson ATG SPP2 frame <span id='am-83' about='obo:IMR_0200318' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-84' property="oboInOwl:hasDbXref" content="KEGG:C00051" datatype="xsd:string"></span><span id='am-85' property="oboInOwl:id" content="IMR:0200318" datatype="xsd:string"></span><span id='am-86' property="rdfs:label" content="Glutathione" datatype="xsd:string"></span><span id='am-87' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>glutathione</span>-S-transferase.        (1993) Pikielney et al. (1986), modifications  <br />                                                                    scribed E. Weidenhammer J.L. Woolford  prep.). <br /> Purification fusion protein                                    prpl6 prpl8 extracts heat inactivated  <br />                                                                    cubation 30 &apos;C 30 min. snrl4 extract prp3 ex- <br /> generation antibodies                                           tract inactivated incubation 37 &apos;C 40 min. GST-Spp2 fusion protein purified E. coli strain       Previously, prp2-1 extracts heat inactivated pre- <br /> NM522 (Stratagene, La JoUa, Calffomia) descxibed Smith       incubation 30-37 &#194;&#176;C (Lustig et al., 1986).  heat <br />  Spp2p required splicing reaction                                                                                     389 <br /> treatment necessary inactivation prp2-1 ex-      isoamylalcohol (50:50:1) ethanol precipitation. RNA <br /> tract prepared strain JWY667. likely      suspended formamide buffer (80% formamide, 1 mM <br /> qualitative differences extract preparation differ-    EDTA, dyes) analyzed urea-acrylamide gels ences strain backgrounds. similar phenomenon          described Roy et al. (1995). Quantification intensity <br /> observed prp2-1 strains R.-J. Lin et al. (pers.        signal performed using Ambis radioanalytic <br /> comm.). Extracts complemented vitro mixing               imaging (Ambis, , San Diego, California). <br /> equal volumes extracts incubating room tem- <br /> perature 10 min prior addition radiolabeled <br /> pre-mRNA. Wild-type extract treated micrococcal            ACKNOWLEDGMENTS <br /> nuclease described Tarn et al. (1993). Mock treatment         acknowledge Dr. Stanley Fields providing yeast extract nuclease accomplished similarly          strain plasmids  hybrid&quot; Dr. Jean water added instead nuclease.                           Beggs pBM125-PRP2 plasmid. thank Elaine <br />    Complementation spp2-1 extract GST-Spp2 car-           Weidenhammer providing prp3 cell extract ried adding 50-200 ng fusion protein 25-,L       Zhen Li GST-rp59 fusion protein. acknowledge <br /> splicing reaction containing 15 tiL spp2-1 extract radio-       members laboratory Drs. R.-J. Lin, Brian C. Ry- <br /> labeled ACT1 pre-mRNA. determine spliceoso-             mond, Beate Schwer valuable discussions criti- <br /> mal complexes formed spp2-1 extract functional,          cal reading manuscript. <br /> 25-tL splicing reactions incubated 30 min 18 &apos;C.           <br /> ATP depleted addition glucose 10 mM fi-          <br /> nal concentration incubation 25 &apos;C 10-15 min. Fifty      <br /> nanograms GST-Spp2 protein added reac-               <br /> tions, increasing concentrations unlabeled <br /> pre-mRNA. reactions incubated additional <br /> 30 min processed usual. experiment           <br /> scribed Figure 7, splicing reactions containing spp2-1 extract    incubated 30 min 18 &apos;C. ATP depleted reactions  reactions supple- <br /> mented wild-type extract absence ATP, heat-          <br /> inactivated prp3 extract presence ATP, 50 ng      <br /> GST-Spp2 protein presence absence ATP,               <br /> dicated figure legend.                                       <br />                                                                      <br />                                                                       <br /> Immunoblot immunoprecipitation analysis                             <br />                                                                  <br /> Total proteins extracted yeast described               <br /> Moritz et al. (1991). immunoblot analysis, protein sam-            <br /> ples boiled 1 x Laemnmli buffer (Laemmli, 1970)      <br /> subjected electrophoresis SDS-10% polyacrylamide gels.       <br /> Proteins transferred electroblotting nitrocellulose          <br /> membrane. immunoblots probed anti-Spp2                    <br /> antibodies, followed incubation goat anti-rabbit im-         <br /> munoglobulin G antibodies conjugated alkaline phospha-               <br /> tase (Promega Corp., Madison, Wisconsin), developed               <br /> according manufacturer&apos;s instructions.                      <br />    Immunoprecipitations splicing reactions             <br /> follows. microliters protein Sepharose beads             <br /> (Promega Corp. Madison, Wisconsin) bound 10 AL                 polyclonal antibodies TET-150 buffer (50 mM Tris-HCl;             <br /> pH 7.5; 1 mM EDTA, 0.1% Triton X-100; 150 mM KCl)              <br /> 2 h room temperature. protein antibody complexes            collected brief centrifugation washed extensively        TET-150 buffer. Fifty-microliter splicing reactions, contain-       <br /> ing 30 AL extract radiolabeled pre-mRNA, bound                 antibody beads 1 h room temperature. im-          <br /> mune complexes collected brief centrifugation        <br /> washed extensively TET-150 buffer 4 &apos;C. Proteins               <br /> eluted lx Laemmli sample buffer subjected immu-            <br /> noblot analysis  immunoprecipitation                   <br /> RNAs, immune complexes digested protein-             <br /> ase K buffer (TET-150 containing 5 mM EDTA, 0.1% SDS,                <br /> 10 Ag/mL E. coli tRNA, 10 ,ug/mL proteinase K) 15 min               37&apos;C, followed extraction phenol/chloroform/                   <br /> </body></html>